PROCTER & GAMBLE HEALTH
|
The Current P/S Ratio of PROCTER & GAMBLE HEALTH is 6.75.
Share Price | ₹4,749.2 | May 03,2024 |
Market Cap | ₹7,883.7 Cr | |
Sales-TTM | ₹1,168.6 Cr | TTM-Standalone Results |
Price/Sales | 6.75x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of PROCTER & GAMBLE HEALTH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹7,883.7 Cr] as on May 03,2024
(/) Sales [ ₹1,168.6 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 6.75x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '6.75 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/S Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PS (Price/Sales) ratio chart of PROCTER & GAMBLE HEALTH
PS Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/e ratio for fiscal years ending Jun2023 to Dec2018 averaged 6.71x.
- PROCTER & GAMBLE HEALTH 's operated at median p/e ratio of 6.24x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/e ratio peaked in Jun2021 at 9.21x.
- PROCTER & GAMBLE HEALTH 's p/e ratio hit its five-year low in Jun2020 of 4.98x.
How does PROCTER & GAMBLE HEALTH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
PROCTER & GAMBLE HEALTH | 1,168.6 | 6.75 | 7,883.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.63 | 361,916.0 |
CIPLA LTD | 25,350.2 | 4.54 | 115,034.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.89 | 105,929.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.27 | 100,322.0 |
DIVIS LABORATORIES LTD | 7,492.8 | 14.00 | 104,873.0 |
MANKIND PHARMA LTD | 9,946.3 | 9.32 | 92,708.2 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.83 | 92,483.6 |
LUPIN LTD | 19,480.1 | 3.87 | 75,438.0 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.42 | 67,541.1 |
ABBOTT INDIA LTD | 5,753.4 | 9.66 | 55,555.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PROCTER & GAMBLE HEALTH 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.42x |
Max industry PS | 14.00x |
Median industry PS | 6.75x |
Average industry PS | 6.93x |
You may also like the below Video Courses